- AdventHealth
Dr. Victor Herrera has been appointed as the chief clinical officer for AdventHealth’s Central Florida Division – South Region. He will oversee the clinical operations and quality of care for the region’s 10 hospitals and more than 2,000 physicians.
“One of our top priorities is planning for the explosive growth Central Florida continues to experience,” Herrera said. “We have a responsibility to care for our community, and as that community grows, we’re going to have to add additional access points for care as well as increase our workforce of caregivers to make sure we continue to live up to that responsibility.”
In addition to his clinical background, Herrera is a champion of using technology to help relieve clinicians from the burden of repetitive tasks to free them up to focus on making medical decisions and to provide a better patient experience.
“As technology improves and becomes more available, we can leverage artificial intelligence and big data to automate tedious tasks, allowing doctors and nurses to spend more meaningful time with their patients,” Herrera said. “Not only can this make for a better patient experience, it can make for a better work experience for our teams as well as help standardize care and reduce costs.”
Dr. Herrera has been with AdventHealth for over 10 years. He previously served as the vice president and chief medical officer for AdventHealth Orlando, the flagship hospital of the AdventHealth system and as the assistant director of the AdventHealth Department of Graduate Medical Education and Internal Medicine Residency Program, where he mentored and trained the next generation of physicians.
“Dr. Herrera is a visionary leader who has a passion for excellence and innovation in health care. He has been instrumental in advancing our clinical quality, safety, and outcomes across our region,” said Brian Adams, CEO of AdventHealth Central Florida – South Region. “I am confident that he will continue to elevate our standards of care and inspire our teams to deliver whole-person care to our communities.”
Dr. Herrera received his medical degree from Universidad del Norte in Colombia, completed his residency in internal medicine at the University of Miami/Jackson Memorial Hospital, and completed dual fellowships in clinical immunology and infectious diseases at the University of Miami and Stanford University, respectively.
He succeeds Dr. Neil Finkler, who retired earlier this year after serving as the chief clinical officer for AdventHealth Central Florida since 2016.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
With an aging population and increases in the prevalence of neurological conditions like Alzheimer’s disease and dementia, physicians and patients alike continue to seek new tools and approaches to...
Empowering emerging women leaders
ATHENA NextGen’s Karen Keene joins AdventHealth’s Karen Corbin in a discussion about empowering the next wave of women leaders.